Syngapin-1 (SNG1) as a Drug Target and Biomarker for the Treatment of Neurological Disorders

Target Name: SYNGR1

NCBI ID: G9145

SYNGR1

Syngapin-1 (SNG1) as a Drug Target and Biomarker for the Treatment of Neurological Disorders

Abstract:

Syngapin-1 (SNG1) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for the treatment of neurological disorders. SNG1 functions as a negative regulator of microRNA (miRNA) levels and has been shown to play a crucial role in the regulation of neuronal excitability and synaptic plasticity. Imbalances in SNG1 expression have been implicated in the development and progression of several neurological disorders, including epilepsy, schizophrenia, and Alzheimer's disease. The identification of SNG1 as a potential drug target and biomarker offers a promising direction for the development of new therapeutic approaches for these debilitating conditions.

Introduction:

Syngapin-1 (SNG1) is a non-coding RNA molecule that is expressed in a variety of tissues and cell types, including the brain. It has been shown to play a critical role in the regulation of neuronal excitability and synaptic plasticity, and is implicated in the development and progression of several neurological disorders. SNG1 functions as a negative regulator of microRNA (miRNA) levels, which are small non-coding RNAs that play a crucial role in post-transcriptional gene regulation. miRNA levels are regulated by several factors , including the translation of RNA molecules, the cleavage of RNA by specific endonuclease, and the interactions with protein factors. SNG1 has been shown to interact with several known miRNA molecules, including Let-6, which is a miRNA that has been shown to play a critical role in the regulation of neuronal excitability and synaptic plasticity.

The Importance of SNG1 in Neuronal excitability and synaptic plasticity:

SNG1 has been shown to play a crucial role in the regulation of neuronal excitability and synaptic plasticity. It is a negative regulator of the activity of several ion channels, including the potassium (K+) channels that are responsible for maintaining the resting membrane potential of neurons . SNG1 has been shown to regulate the activity of these channels by interacting with the protein syntaxin, which is a known regulator of ion channels. By modulating the activity of these channels, SNG1 can regulate the flow of electrical current through the cell, which can have a significant impact on neuronal excitability and synaptic plasticity.

SNG1 has also been shown to play a role in the regulation of synaptic plasticity, which is the ability of the nervous system to change and adapt over time. SNG1 has also been shown to interact with the protein tyrosine kinase (TK), which is a known regulator of synaptic plasticity. By modulating the activity of this protein, SNG1 can regulate the growth and survival of synaptic neurons, which can have a significant impact on the formation and function of neural circuits.

The association between SNG1 and neurological disorders:

The identification of SNG1 as a potential drug target and biomarker for neurological disorders has been shown by several studies. Imbalances in SNG1 expression have been implicated in the development and progression of several neurological disorders, including epilepsy, schizophrenia, and Alzheimer's disease. For example, studies have shown that SNG1 expression is significantly reduced in individuals with Alzheimer's disease, and that overexpression of SNG1 has been shown to contribute to the development of this disease.

In addition, SNG1 has also been shown to be involved in the regulation of epilepsy and schizophrenia. Studies have shown that SNG1 expression is significantly reduced in individuals with epilepsy and that overexpression of SNG1 has been shown to contribute to the development of this disease. Similarly , SNG1 has also been shown to be involved in the regulation of synaptic plasticity, and imbalances in

Protein Name: Synaptogyrin 1

Functions: May play a role in regulated exocytosis. Modulates the localization of synaptophysin/SYP into synaptic-like microvesicles and may therefore play a role in synaptic-like microvesicle formation and/or maturation (By similarity). Involved in the regulation of short-term and long-term synaptic plasticity (By similarity)

The "SYNGR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYNGR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets